Media-Based Glycan Engineering for Biosimilars: Your Rapid Implementation Guide
When raffinose works, when it doesn’t, and a 3-experiment protocol to validate it for your process in 8 weeks.
Media-Based Glycan Engineering for Biosimilars: Achieving Reference Product Match
Why pistachios sabotaged cyclists’ performance — and the raffinose mechanism behind it.
Why Your Funding Pitches Fail Despite Brilliant Science (And How to Fix It) – Part 2
Ever watched judges’ faces light up during your pitch?
Why Your Funding Pitches Fail Despite Brilliant Science (And How to Fix It) – Part 1
Ever stood in front of a room full of executives, your heart pounding, wondering why your brilliant science isn’t connecting?
When the Innovator Becomes the Patient: Manufacturing Reality vs. Patient Urgency – Part 2
What happens when therapeutic innovation meets real patient urgency?
When the Innovator Becomes the Patient: Manufacturing Reality vs. Patient Urgency – Part 1
Real urgency in healthcare means balancing safety, impact, and accessibility—not just speeding to market.
Crafting a Solid CMC Strategy: Key Factors and Common Pitfalls
What’s the single most formidable hurdle for a promising biotech breakthrough? It’s crafting a robust CMC (Chemistry, Manufacturing, and Controls) strategy.
Effective Outsourcing: How Small Biotech Companies Can Thrive
Bioprocess development and manufacturing are often perceived as sources of potential high-stakes problems, frequently cited as contributing to program failures.